- Home
- PEP vs AZN Comparison
PEP vs AZN Comparison
Compare PEP & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEP
- AZN
- Stock Information
- Founded
- PEP 1898
- AZN 1992
- Country
- PEP United States
- AZN United Kingdom
- Employees
- PEP N/A
- AZN N/A
- Industry
- PEP Beverages (Production/Distribution)
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- PEP Consumer Staples
- AZN Health Care
- Exchange
- PEP Nasdaq
- AZN Nasdaq
- Market Cap
- PEP 204.8B
- AZN 205.5B
- IPO Year
- PEP N/A
- AZN 1993
- Fundamental
- Price
- PEP $133.38
- AZN $69.57
- Analyst Decision
- PEP Buy
- AZN Strong Buy
- Analyst Count
- PEP 14
- AZN 6
- Target Price
- PEP $162.54
- AZN $89.75
- AVG Volume (30 Days)
- PEP 9.1M
- AZN 6.7M
- Earning Date
- PEP 04-24-2025
- AZN 04-29-2025
- Dividend Yield
- PEP 4.06%
- AZN 2.21%
- EPS Growth
- PEP 2.41
- AZN 18.11
- EPS
- PEP 6.80
- AZN 4.50
- Revenue
- PEP $91,523,000,000.00
- AZN $54,073,000,000.00
- Revenue This Year
- PEP $1.29
- AZN $8.64
- Revenue Next Year
- PEP $3.55
- AZN $6.11
- P/E Ratio
- PEP $19.61
- AZN $30.51
- Revenue Growth
- PEP N/A
- AZN 18.04
- 52 Week Low
- PEP $131.80
- AZN $61.24
- 52 Week High
- PEP $183.41
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- PEP 32.43
- AZN 49.07
- Support Level
- PEP $139.77
- AZN $66.59
- Resistance Level
- PEP $144.28
- AZN $68.40
- Average True Range (ATR)
- PEP 4.34
- AZN 1.99
- MACD
- PEP -0.90
- AZN 0.41
- Stochastic Oscillator
- PEP 10.27
- AZN 97.43
About PEP PepsiCo Inc.
PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 55% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US and overseas. International markets make up 40% of total sales and one third of operating profits.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.